CHEOY
Cochlear Limited
Set alert
50.26 USD +0.42 +0.84%
50.26 Day range 50.31
31.90 52-week range 97.58
- YTD
- -41.85%
- 1 year
- -47.49%
- Open
- 50.31
- Prev close
- 49.84
- Mkt cap
- 6.57B
- Vol
- 311
- Avg vol
- 19.95K
- EPS
- 0.76
- P/E
- 66.13
More statistics
- Low
- 50.26
- High
- 50.31
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2026 | Dec 31, 2025 | — | 0.811 | — | — |
| Aug 18, 2025 | Jun 30, 2025 | — | 0.915 | — | — |
| Feb 13, 2025 | Dec 30, 2024 | — | 0.967 | — | — |
| Aug 15, 2024 | Jun 30, 2024 | — | 0.839 | — | — |
| Feb 18, 2024 | Dec 31, 2023 | — | 0.992 | — | — |
| Jun 30, 2023 | Jun 30, 2023 | — | 0.80 | — | — |
News
- Cochlear Limited (CHEOY) Shareholder/Analyst Call Prepared Remarks Transcript
- CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Stock Now Rated “Hold” by Sell-Side Analysts
- Cochlear to defend shareholder class action over 2026 profit forecast
- Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program
- Cochlear Limited (CHEOY) Q4 2026 Earnings Call Transcript
- CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Sees Significant Drop in Short Interest
- Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
- Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants
- Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
- MED-EL USA Presents Real World Clinical Insights to Support Tailored Hearing Solutions at the 2026 American Cochlear Implant Association Meeting
Your note
Sign in to keep a note on CHEOY — it syncs with the Stock Master app.